Flaherty LE, Gadgeel SM. Biochemotherapy of melanoma. Semin Oncol 2002; 5:446.

Gilchrest BA, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340:1341.

Grob JJ, et al. (French Cooperative Group on Melanoma). Randomised trial of interferon alfa-2 as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable lymph node metastases. Lancet 1998; 351:1905.

Kirkwood JM, et al. Interferon alfa-2b adjuvant therapy of high- risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996; 14:7.

Lens M B, Dawes M. Interferon alfa therapy for malignant melanoma: A systematic review of randomized controlled trials. J Clin Oncol 2002; 20:1818.

Lens MB, Dawes M. Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trials. Lancet Oncol 2003; 4:359.

McClay EF. Adjuvant therapy for patients with high-risk melanoma. Semin Oncol 2002; 29:389.

McMasters KM, et al. Sentinal LN biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001; 19:2851.

Vongtama R, et al. Efficacy of radiation therapy in the local control of des- moplastic malignant melanoma. Head Neck 2003; 25:423.


  • :